Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States.|https://dx.doi.org/10.1007/s40121-025-01169-4
Oligomerization of the Clostridioides difficile Transferase B Component Proceeds through a Stepwise Mechanism.|https://dx.doi.org/10.1101/2025.05.06.652354
Optimizing Prevention of Recurrent Urinary Tract Infections in Older Patients with Frailty.|https://dx.doi.org/10.1007/s40266-025-01230-4
Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study.|https://dx.doi.org/10.7759/cureus.86045
Decreased Antimicrobial Resistance Gene Richness Following Fecal Microbiota, Live-jslm (REBYOTAÂ®) Administration: Post Hoc Analysis of PUNCH CD3.|https://dx.doi.org/10.1093/ofid/ofaf382
Oligomerization of the Clostridioides difficile transferase B component proceeds through a stepwise mechanism.|https://dx.doi.org/10.1371/journal.ppat.1013186
Exploring the effects of faecal microbiota transplantation on cognitive function: A review of clinical trials.|https://dx.doi.org/10.1016/j.bbih.2025.101049
Clostridioides difficile co-infection worsens prognosis in inflammatory bowel disease in patients with cytomegalovirus colitis.|https://dx.doi.org/10.1007/s00384-025-04954-2
The host genes influencing Clostridioides difficile infection and the potential role of intestinal Lactobacillus acidophilus: a Mendelian randomization and animal model study.|https://dx.doi.org/10.3389/fcimb.2025.1607476
Biofilm Assay for Clostridioides difficile with Applications for Drug Discovery.|https://dx.doi.org/10.3791/67913
The analysis of the epidemic status and risk factors associated with different genotypes Clostridioides difficile mixed infection.|https://dx.doi.org/10.1186/s12866-025-04182-2
